| |
|
|
|
|
|
|
|||
|
Blood, 15 August 2007, Vol. 110, No. 4, pp. 1091.
Editorial Notes from the Director, National Heart, Lung, and Blood Institute: NHLBI core values and shaping the 2007 budgetNational Heart, Lung, and Blood Institute, National Institutes of HealthBethesda, MD With fiscal year 2007 well under way, we write to report on the status of our budget for the National Heart, Lung, and Blood Institute (NHLBI). As a result of a Congressional joint resolution, the NHLBI received an allocation of US $2 918 808 000, which represents an increase of about 1% over the comparable figure for fiscal year 2006. The NHLBI has a long-standing and powerful commitment to preserve and enhance investigator-initiated research and to develop and support new investigators. In these difficult times, the Institute's top priorities will be to stay true to these core values. To accomplish this objective, we have developed a number of strategies to assist investigators in launching successful research careers and riding out tough times. Several policies are designed to ease the path to independence for new investigators. (http://www.nhlbi.nih.gov/funding/policies/operguid.htm)
In addition to the measures mentioned above, we are pleased to report that in fiscal year 2007, the NIH Common Fund is receiving a direct allocation from Congress, such that NHLBI monies that would have been committed to NIH Roadmap programs will now be retained by the Institute. This amounts to about $35 million, which will be used to bolster investigator-initiated research and training programs. We appreciate the expertise and wisdom that the scientific community provided in the development of our newly completed Strategic Plan (http://www.nhlbi.nih.gov/strategicplan/). You will be hearing more from us about the Strategic Plan in the coming months. We anticipate that many of the goals stated within the Strategic Plan will be accomplished through investigator-initiated research. Our commitments to supporting investigator-initiated research and new investigators may require that we scale back to some extent the development of Institute-initiated programs. It will also require that we establish a judicious timetable for implementing our Strategic Plan. We are grateful for the generous support that the NHLBI has received from the community of investigators it serves, and we look forward to close collaborations with you as we push the frontiers of biomedical science forward. We will continue to do everything in our power to limit the adverse effects of the current budget constraints and preserve the vitality and momentum of the research enterprise. We welcome comments, questions, and concerns and are pleased to hear from readers at any time. We look forward to continuing to work with you as we face our challenges and opportunities together.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2007 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||